Your browser doesn't support javascript.
loading
mitoBKCa is functionally expressed in murine and human breast cancer cells and potentially contributes to metabolic reprogramming.
Bischof, Helmut; Maier, Selina; Koprowski, Piotr; Kulawiak, Bogusz; Burgstaller, Sandra; Jasinska, Joanna; Serafimov, Kristian; Zochowska, Monika; Gross, Dominic; Schroth, Werner; Matt, Lucas; Juarez Lopez, David Arturo; Zhang, Ying; Bonzheim, Irina; Büttner, Florian A; Fend, Falko; Schwab, Matthias; Birkenfeld, Andreas L; Malli, Roland; Lämmerhofer, Michael; Bednarczyk, Piotr; Szewczyk, Adam; Lukowski, Robert.
Affiliation
  • Bischof H; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Maier S; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Koprowski P; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Kulawiak B; Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
  • Burgstaller S; Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
  • Jasinska J; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Serafimov K; NMI Natural and Medical Sciences Institute at the University of Tübingen, Reutlingen, Germany.
  • Zochowska M; Center for Medical Research, CF Bioimaging, Medical University of Graz, Graz, Austria.
  • Gross D; Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
  • Schroth W; Institute of Pharmaceutical Sciences, Pharmaceutical (Bio-)Analysis, University of Tübingen, Tübingen, Germany.
  • Matt L; Laboratory of Intracellular Ion Channels, Nencki Institute of Experimental Biology, Polish Academy of Sciences, Warsaw, Poland.
  • Juarez Lopez DA; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Zhang Y; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Bonzheim I; University of Tübingen, Tübingen, Germany.
  • Büttner FA; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Fend F; Medical Clinic IV, University Hospital Tübingen, Tübingen, Germany.
  • Schwab M; Department of Pharmacology, Toxicology and Clinical Pharmacy, Institute of Pharmacy, University of Tübingen, Tübingen, Germany.
  • Birkenfeld AL; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
  • Malli R; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Lämmerhofer M; University of Tübingen, Tübingen, Germany.
  • Bednarczyk P; Institute of Pathology and Neuropathology, University Hospital Tübingen, Tübingen, Germany.
  • Szewczyk A; Dr Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.
  • Lukowski R; iFIT Cluster of Excellence (EXC 2180) "Image-guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Germany.
Elife ; 122024 May 29.
Article in En | MEDLINE | ID: mdl-38808578
ABSTRACT
Alterations in the function of K+ channels such as the voltage- and Ca2+-activated K+ channel of large conductance (BKCa) reportedly promote breast cancer (BC) development and progression. Underlying molecular mechanisms remain, however, elusive. Here, we provide electrophysiological evidence for a BKCa splice variant localized to the inner mitochondrial membrane of murine and human BC cells (mitoBKCa). Through a combination of genetic knockdown and knockout along with a cell permeable BKCa channel blocker, we show that mitoBKCa modulates overall cellular and mitochondrial energy production, and mediates the metabolic rewiring referred to as the 'Warburg effect', thereby promoting BC cell proliferation in the presence and absence of oxygen. Additionally, we detect mitoBKCa and BKCa transcripts in low or high abundance, respectively, in clinical BC specimens. Together, our results emphasize, that targeting mitoBKCa could represent a treatment strategy for selected BC patients in future.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Animals / Female / Humans Language: En Journal: Elife Year: 2024 Type: Article Affiliation country: Germany

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms Limits: Animals / Female / Humans Language: En Journal: Elife Year: 2024 Type: Article Affiliation country: Germany